Endothelial cell functions

Journal of Cellular Physiology

Volumn 196, Issue 3, 2003, Pages 430-443

  Michiels, Carine ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BLOOD CLOTTING; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CELL FUNCTION; CELL STRUCTURE; ENDOTHELIUM CELL; FIBRINOLYSIS; HOMEOSTASIS; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVIEW; THROMBOSIS; TUMOR VASCULARIZATION;

ANIMALS; BLOOD COAGULATION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; MUSCLE TONUS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0041767435     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10333     Document Type: Review

References (153)

1. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295-306.
2. Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. 1994. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 269:10112-10118.
3. Alexander JS, Elrod JW. 2002. Extracellular matrix, junctional integrity, and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 200:561-574.
4. Allport JR, Muller WA, Luscinskas FW. 2000. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol 148:203-216.
5. Altieri DC, Edgington TS. 1988. A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 141:2656-2660.
6. Anderson DC, Springer TA. 1987. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 38:175-194.
7. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. 1999. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55:1078-1087.
8. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
9. Baldwin AL, Thurston G. 2001. Mechanics of endothelial cell architecture and vascular permeability. Crit Rev Biomed Eng 29:247-278.
10. Barnes PJ, Karin M. 1997. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
11. Bazzoni G, Martinez Estrada O, Dejana E, Schnittler HJ. 1999. Molecular structure and functional role of vascular tight junctions. Trends Cardiovasc Med 9:147-152.
12. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. 1989. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160-1165.
13. Bierhaus A, Chen J, Liliensiek B, Nawroth PP. 2000. LPS and cytokine-activated endothelium. Semin Thromb Hemost 26:571-587.
14. Bogatcheva NV, Garcia JG, Verin AD. 2002. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 67:75-84.
15. Bouck N, Stellmach V, Hsu SC. 1996. How tumors become angiogenic. Adv Cancer Res 69:135-174.
16. Bussolino F, Camussi G, Tetta C, Garbarino G, Bosia A, Baglioni C. 1990. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: Comparison between tumor necrosis factor alpha and beta and interleukin-1. J Lipid Mediat 2:S15-S22.
17. Buyon JP, Philips MR, Merrill JT, Slade SG, Leszczynska-Piziak J, Abramson SB. 1997. Differential phosphorylation of the beta2 integrin CD11b/CD18 in the plasma and specific granule membranes of neutrophils. J Leukoc Biol 61:313-321.
18. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
19. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
20. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
21. Chen J, Bierhaus A, Schiekofer S, Andrassy M, Chen B, Stern DM, Nawroth PP. 2001. Tissue factor - a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 86:334-345.
22. Chien S, Li S, Shyy YJ. 1998. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 31:162-169.
23. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561.
24. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899-909.
25. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC, Laudanna C. 2000. Chemokines trigger immediate beta2 integrin affinity and mobility changes: Differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-769.
26. Coughlin SR. 1999. How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023-11027.
27. Coughlin SR. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258-264.
28. Cowan CA, Henkemeyer M. 2002. Ephrins in reverse, park, and drive. Trends Cell Biol 12:339-346.
29. Dachs GU, Tozer GM. 2000. Hypoxia modulated gene expression: Angiogenesis, metastasis, and therapeutic exploitation. Eur J Cancer 36:1649-1660.
30. Davie EW, Fujikawa K, Kisiel W. 1991. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30:10363-10370.
31. de Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. 1992. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85:2284-2290.
32. Dejana E. 1996. Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949-1953.
33. Dejana E, Corada M, Lampugnani MG. 1995. Endothelial cell-to-cell junctions. FASEB J 9:910-918.
34. Denis CV. 2002. Molecular and cellular biology of von Willebrand factor. Int J Hematol 75:3-8.
35. Denninger JW, Marletta MA. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411:334-350.
36. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW. 1999. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162:3022-3030.
37. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97-132.
38. Ebnet K, Vestweber D. 1999. Molecular mechanisms that control leukocyte extravasation: The selectins and the chemokines. Histochem Cell Biol 112:1-23.
39. Emeis JJ. 1995. The control of tPA and PAI release from the vessel wall. Vasc Med Rev 6:153-166.
40. Eriksson U, Alitalo K. 1999. Structure, expression, and receptor-binding properties of novel vascular endothelial growth factors. Curr Top Microbiol Immunol 237:41-57.
41. Esmon CT. 1995. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946-955.
42. Esmon CT. 2000. The endothelial cell protein C receptor. Thromb Haemost 83:639-643.
43. Etzioni A, Doerschuk CM, Harlan JM. 1999. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies. Blood 94:3281-3288.
44. Ferrara N. 1999. Vascular endothelial growth factor: Molecular and biological aspects. Curr Top Microbiol Immunol 237:1-30.
45. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
46. Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, Springer TA. 1996. Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature 379:266-269.
47. Flanagan JG, Vanderhaeghen P. 1998. The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21:309-345.
48. Fleming I, Bauersachs J, Busse R. 1996. Paracrine functions of the coronary vascular endothelium. Mol Cell Biochem 157:137-145.
49. Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186.
50. Folkman J. 1990. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev 9:171-174.
51. Foxman EF, Campbell JJ, Butcher EC. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139:1349-1360.
52. Furchgott RF. 1988. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for proposal that the acid activable factor from bovine retractor penis is inorganic nitrite and the endothelium derived relaxing factor is nitric oxide. In: Vanhoutte PM, editor. Mechanisms of vasodilatation. New York: Raven Press. pp 427-435.
53. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
54. Gale NW, Yancopoulos GD. 1999. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066.
55. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403-414.
56. Ghosh DK, Salerno JC. 2003. Nitric oxide synthases: Domain structure and alignment in enzyme function and control. Front Biosci 8:D193-D209.
57. Govers R, Rabelink TJ. 2001. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol 280:F193-F206.
58. Griffith OW, Stuehr DJ. 1995. Nitric oxidase synthases: Properties and catalytic mechanism. Annu Rev Physiol 57:707-736.
59. Gross PL, Aird WC. 2000. The endothelium and thrombosis. Semin Thromb Hemost 26:463-478.
60. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
61. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156:1363-1380.
62. Helmlinger G, Yuan F, Dellian M, Jain RK. 1997. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med 3:177-182.
63. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. 1998. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607-4612.
64. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998.
65. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. 1993. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 120:1371-1380.
66. Hynes RO. 1992. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
67. Jalali S, del Pozo MA, Chen K, Miao H, Li Y, Schwartz MA, Shyy JY, Chien S. 2001. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci USA 98:1042-1046.
68. Johnson-Léger C, Aurrand-Lions M, Imhof BA. 2000. The parting of the endothelium: Miracle or simply a junctional affair? J Cell Sci 113:921-933.
69. Kato H. 2002. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: Basic and clinical aspects. Arterioscler Thromb Vasc Biol 22:539-548.
70. Kedzierski RM, Yanagisawa M. 2001. Endothelin system: The double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851-876.
71. Klein CL, Bittinger F, Skarke CC, Wagner M, Kohler H, Walgenbach S, Kirkpatrick CJ. 1995. Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology 63:204-212.
72. Komori K, Vanhoutte PM. 1990. Endothelium-derived hyperpolarizing factor. Blood Vessels 27:238-245.
73. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. 1999. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease. J Interferon Cytokine Res 19:91-104.
74. Lavallee M, Takamura M, Parent R, Thorin E. 2001. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6:265-276.
75. Ley K. 2002. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186:8-18.
76. Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA. 1995. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182:1337-1343.
77. Liekens S, De Clercq E, Neyts J. 2001. Angiogenesis: Regulators and clinical applications. Biochem Pharmacol 61:253-270.
78. Luscinskas FW, Lawler J. 1994. Integrins as dynamic regulators of vascular function. FASEB J 8:929-938.
79. Mackman N. 1997. Regulation of the tissue factor gene. Thromb Haemost 78:747-754.
80. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
81. Malek AM, Izumo S. 1996. Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress. J Cell Sci 109:713-726.
82. Mantovani A, Bussolino F, Dejana E. 1992. Cytokine regulation of endothelial cell function. FASEB J 6:2591-2599.
83. Marletta MA. 2001. Another activation switch for endothelial nitric oxide synthase: Why does it have to be so complicated? Trends Biochem Sci 26:519-521.
84. McEver RP, Cummings RD. 1997. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100:S97-S103.
85. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. 1989. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 84:92-99.
86. Moncada S, Gryglewski R, Bunting S, Vane JR. 1976. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665.
87. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. 2002. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985-1000.
88. Muller WA. 2002. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 82:521-533.
89. Muller WA, Randolph GJ. 1999. Migration of leukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66:698-704.
90. Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593-633.
91. Nathan C. 2002. Points of control in inflammation. Nature 420:846-852.
92. Nawroth PP, Handley DA, Esmon CT, Stern DM. 1986. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83:3460-3464.
93. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22.
94. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, Muller WA. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222.
95. Nickel R, Beck LA, Stellato C, Schleimer RP. 1999. Chemokines and allergic disease. J Allergy Clin Immunol 104:723-742.
96. Nordsmark M, Bentzen SM, Overgaard J. 1994. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intra-tumour heterogeneity. Acta Oncol 33:383-389.
97. Oxvig C, Lu C, Springer TA. 1999. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc Natl Acad Sci USA 96:2215-2220.
98. Palmer RM, Ferrige AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
99. Pearson JD. 1999. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol 12:329-341.
100. Pearson JD, Carleton JS, Gordon JL. 1980. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 190:421-419.
101. Pober JS. 1987. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 131:170-184.
102. Pober JS, Cotran RS. 1990. Cytokines and endothelial cell biology. Physiol Rev 70:427-451.
103. Preissner KT. 2000. Hemostatic protease receptors and endothelial cell function: Insights from gene targeting in mice. Semin Thromb Hemost 26:451-462.
104. Prescott SM, McIntyre TM, Zimmerman GA. 2001. Events at the vascular wall: The molecular basis of inflammation. J Investig Med 49:104-111.
105. Pries AR, Secomb TW, Gaehtgens P. 2000. The endothelial surface layer. Pflugers Arch 440:653-666.
106. Reinhart WH. 1994. Shear-dependence of endothelial functions. Experientia 50:87-93.
107. Resnick N, Gimbrone MA. 1995. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9:874-882.
108. Rollins BJ. 1997. Chemokines. Blood 90:909-928.
109. Rubanyi GM, Botelho LH. 1991. Endothelins. FASEB J 5:2713-2720.
110. Ruggeri ZM, Preissner KT. 1999. Structure and function of von Willebrand factor. Thromb Haemost 82:576-584.
111. Saaristo A, Karpanen T, Alitalo K. 2000. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 19:6122-6129.
112. Sadler JE. 1997. Thrombomodulin structure and function. Thromb Haemost 78:392-395.
113. Sakurai T, Yanagisawa M, Masaki T. 1992. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-103.
114. Sase K, Michel T. 1997. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 7:28-37.
115. Sato TN, Qin Y, Kozak CA, Audus KL. 1993. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci 90:9355-9358.
116. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
117. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 3:143-150.
118. Schmidt HH, Lohmann SM, Walter U. 1993. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1178:153-175.
119. Schnittler HJ. 1998. Structural and functional aspects of intercellular junctions in vascular endothelium. Basic Res Cardiol 93:30-39.
120. Scholz D, Devaux B, Hirche A, Potzsch B, Kropp B, Schaper W, Schaper J. 1996. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res 284:415-423.
121. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
122. Semenza GL. 2000a. HIF-1: Using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19:59-65.
123. Semenza GL. 2000b. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1:159-162.
124. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
125. Sidelmann JJ, Gram J, Jespersen J, Kluft C. 2000. Fibrin clot formation and lysis: Basic mechanisms. Semin Thromb Hemost 26:605-618.
126. Simon SI, Cherapanov V, Nadra I, Waddell TK, Seo SM, Wang Q, Doerschuk CM, Downey GP. 1999. Signaling functions of L-selectin in neutrophils: Alterations in the cytoskeleton and colocalization with CD18. J Immunol 163:2891-2901.
127. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745.
128. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314.
129. Stern DM, Esposito C, Gerlach H, Gerlach M, Ryan J, Handley D, Nawroth P. 1991. Endothelium and regulation of coagulation. Diabetes Care 14:160-106.
130. Stewart M, Thiel M, Hogg N. 1995. Leukocyte integrins. Curr Opin Cell Biol 7:690-696.
131. Stuehr DJ. 1999. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411:217-230.
132. i signaling during transmigration of polymorphonuclear leukocytes. Blood 96:3816-3822.
133. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
134. Tanaka Y, Adams DH, Shaw S. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14:111-115.
135. Tedder TF, Steeber DA, Chen A, Engel P. 1995. The selectins: Vascular adhesion molecules. FASEB J 9:866-873.
136. Traub O, Berk BC. 1998. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18:677-685.
137. Turner AJ, Barnes K, Schweizer A, Valdenaire O. 1998. Isoforms of endothelin-converting enzyme: Why and where? Trends Pharmacol Sci 19:483-486.
138. van Mourik JA, Romani de Wit T, Voorberg J. 2002. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 117:113-122.
139. Varki A. 1997. Selectin ligands: Will the real ones please stand up? J Clin Invest 100:S31-S35.
140. Vestweber D. 2000. Molecular mechanisms that control endothelial cell contacts. J Pathol 190:281-291.
141. Wagner JG, Roth RA. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52:349-374.
142. Ward SG, Bacon K, Westwick J. 1998. Chemokines and T lymphocytes: More than an attraction. Immunity 9:1-11.
143. Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 90:7158-7162.
144. Weber C, Springer TA. 1998. Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration. J Immunol 161:6825-6834.
145. Wenger RH, Gassmann M. 1997. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378:609-616.
146. Williams MA, Solomkin JS. 1999. Integrin-mediated signaling in human neutrophil functioning. J Leukoc Biol 65:725-736.
147. Willmroth F, Beaudet AL. 1999. Structure of the murine E-selectin ligand 1 (ESL-1) gene and assignment to Chromosome 8. Mamm Genome 10:1085-1088.
148. Worthylake RA, Burridge K. 2001. Leukocyte transendothelial migration: Orchestrating underlying molecular machinery. Curr Opin Cell Biol 13:569-577.
149. Xiao Z, Zhang Z, Ranjan V, Diamond SL. 1997. Shear stress induction of the endothelial nitric oxide synthase gene is calcium-dependent but not calcium-activated. J Cell Physiol 171:205-211.
150. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.
151. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
152. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. 1990. Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 110:529-540.
153. Zimmerman GA, Elstad MR, Lorant DE, McLntyre TM, Prescott SM, Topham MK, Weyrich AS, Whatley RE. 1996. Platelet-activating factor (PAF): Signalling and adhesion in cell-cell interactions. Adv Exp Med Biol 416:297-304.